申请人:Metro International Biotech, LLC
公开号:US11180521B2
公开(公告)日:2021-11-23
Provided herein are compounds of Formula (I) and their salts, and compositions comprising such compounds that are useful for increasing the amount of NAD+ in cells. Also disclosed are methods of using the disclosed compounds and compositions for treating, for example, diseases or disorders related to aging or stress, diabetes, obesity, mitochondrial diseases, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing.
本文提供了式(I)化合物及其盐类,以及包含此类化合物的组合物,它们有助于增加细胞中的NAD+含量。还公开了使用所公开的化合物和组合物治疗与衰老或压力、糖尿病、肥胖、线粒体疾病、神经退行性疾病、心血管疾病、凝血障碍、炎症、癌症和/或潮红等有关的疾病或紊乱的方法。